OverviewSuggest Edit

iXensor is a health technology company. Its PixoTest system can turn mobile devices into in vitro diagnostic medical devices. iXensor's solution enables users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
TypePublic
Founded2012
HQTW
Websiteixensor.com

Latest Updates

Share Price (Nov 2021)NT$16.1
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at iXensor

Peter Fitzgerald

Peter Fitzgerald

Chairman
Carson Chen

Carson Chen

Chief Executive Officer & Co-Founder
Show more

iXensor Office Locations

iXensor has an office in
Show all (1)

iXensor Financials and Metrics

iXensor Revenue

Market capitalization (10-Nov-2021)

748.5m

Closing stock price (10-Nov-2021)

16.1
iXensor's current market capitalization is NT$748.5 m.
Show all financial metrics

iXensor Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

iXensor Online and Social Media Presence

Embed Graph

iXensor News and Updates

iXensor Levels Up PixoTest Covid-19 Ag Test With The Launch Of PixoHealth Data Management Platform As The Security Solution For The New Normalcy

The GDPR-compliant PixoHealth Pass Admin Solution works with PixoTest® POCT COVID-19 Antigen Test to help organizations maintain COVID-19 free environments The PixoTest® POCT COVID-19 Antigen Test detects the key SARS-CoV-2 variants, including Alpha, Beta, Gamma and Delta Connected...

iXensor Launches CE-marked Fully Digitized PixoTest COVID-19 Rapid Test with Digital Health Pass to Facilitate Safe Reopening of Economies

A computer vision empowered rapid antigen test to avoid human errors. An end-to-end digitized screening solution delivers test-to-report time in around 15 minutes. The enterprise SaaS solution enables organizations to reopen with confidence. TAIPEI, June 3, 2021 /PRNewswire/ -- iXensor Co....

iXensor to close the loop of COVID-19 outbreak prevention with the fully digitalized rapid antigen test and an encrypted mobile pass

TAIPEI, TAIWAN and PALO ALTO, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- iXensor Co., Ltd. (6734.TWO)

iXensor Frequently Asked Questions

  • When was iXensor founded?

    iXensor was founded in 2012.

  • Who are iXensor key executives?

    iXensor's key executives are Peter Fitzgerald and Carson Chen.

  • Who are iXensor competitors?

    Competitors of iXensor include CloudCath, Neuro Device and Ativa Medical.

  • Where are iXensor offices?

    iXensor has an office in.

  • How many offices does iXensor have?

    iXensor has 1 office.